The analysis confirmed a significant increase in Serpina3 in HF (P < .001) as shown in Figure 4A. Additionally, the circulating levels of Seprina3 were measured in patients with (n = 28) or without HF (n = 88) at admission. This evidence concerns the gene SERPINA3 and hydrops fetalis.